Elmwood Wealth Management Inc. Grows Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

Elmwood Wealth Management Inc. increased its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 7.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 62,191 shares of the company’s stock after buying an additional 4,425 shares during the quarter. Elmwood Wealth Management Inc. owned about 0.11% of ARK Genomic Revolution ETF worth $1,464,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in ARKG. JPMorgan Chase & Co. boosted its holdings in ARK Genomic Revolution ETF by 31.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,955,279 shares of the company’s stock valued at $75,655,000 after purchasing an additional 698,701 shares in the last quarter. Atom Investors LP boosted its holdings in ARK Genomic Revolution ETF by 15.2% in the 3rd quarter. Atom Investors LP now owns 49,131 shares of the company’s stock valued at $1,258,000 after purchasing an additional 6,496 shares in the last quarter. Barclays PLC boosted its holdings in ARK Genomic Revolution ETF by 252.7% in the 3rd quarter. Barclays PLC now owns 285,108 shares of the company’s stock valued at $7,299,000 after purchasing an additional 204,283 shares in the last quarter. National Bank of Canada FI boosted its holdings in ARK Genomic Revolution ETF by 28.4% in the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after purchasing an additional 920 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV boosted its holdings in ARK Genomic Revolution ETF by 901.5% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 28,943 shares of the company’s stock valued at $680,000 after purchasing an additional 26,053 shares in the last quarter.

ARK Genomic Revolution ETF Trading Down 3.2 %

ARKG traded down $0.83 during trading on Monday, reaching $24.74. The company’s stock had a trading volume of 4,522,846 shares. The firm has a 50-day moving average of $24.86 and a two-hundred day moving average of $25.02.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.